#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Mantle cell lymphoma stage III Chronic graft versus host disease in intestine Vascular malformation Staphylococcal infection Cystic fibrosis Acute hepatic failure Eosinophilic granulomatosis with polyangiitis Pancreatic carcinoma metastatic Cutaneous T-cell lymphoma Hereditary ataxia Retinal dystrophy Ependymoma Synovial sarcoma recurrent Mixed-type liposarcoma More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Trials in Disease Amyotrophic lateral sclerosis – Life with Disease Richter’s syndrome – Basic Information Crigler-Najjar syndrome – Life with Disease Marfan’s syndrome – Basic Information Sjogren’s syndrome – Basic Information Pulmonary fibrosis – Diagnostics Burkitt’s lymphoma – Treatment Splenic marginal zone lymphoma – Trials in Disease Hereditary hypophosphataemic rickets More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hexaminolevulinate Gallium (68Ga) Psma-R2 Bleomycin Sulfate Omo-103 Aciclovir ZOLPIDEM TARTRATE Evx-01 Cetrimide Enalapril H2-Receptor Antagonist E2814 Alitretinoin L-LEUCINE Flortaucipir (18F) 177LU-PSMA-I&T Codeine Phosphate Bulevirtide Sodium Alginate Eliglustat Tartrate PRT3789 More therapies…

    Learn about Your Condition

    Arterial tortuosity syndrome Spinal muscular atrophy Benign renal neoplasm Eczema Lymphocyte adoptive therapy Hyperphagia Laryngeal cancer stage II EGFR gene mutation Blood iron increased Coronary artery dissection Endocarditis enterococcal Atrial fibrillation Noonan syndrome Pulmonary vascular disorder Infant sedation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Cabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir
    • Rilpivirine
    Spain

  • Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Abacavir
    • Atazanavir
    • Cobicistat
    France Germany Italy The Netherlands Poland Spain

  • Switching to Lenacapavir-based drug combination vs cabotegravir-based drug combination in virologically suppressed adults with HIV-1

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabotegravir
    • Lenacapavir
    • Rilpivirine
    France Germany Italy The Netherlands Poland Spain

  • A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Pyrimethamine
    • Topiramate
    • Lenalidomide
    The Netherlands

  • A study of islatravir and ulonivirine for adults with HIV who have not received previous treatment

    Recruiting

    4 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Islatravir
    • Ulonivirine
    • Emtricitabine
    France Spain

  • A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Vh4524184
    • Dolutegravir Sodium
    • Emtricitabine
    Belgium France Germany Italy Poland Portugal +1
1 2 3 … 13
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!